9 research outputs found
Clinical Characteristics and Prognosis of 244 Cardiovascular Patients Suffering From Coronavirus Disease in Wuhan, China
Value of neutrophil-to-lymphocyte ratio as a marker of renal damage in patients with H-type hypertension
Evaluation of Group Visits for Chinese Hypertensives Based on Primary Health Care Center
Longitudinal association between physical activity and blood pressure, risk of hypertension among Chinese adults: China Health and Nutrition Survey 1991ā2015
Effects of nighttime sleep duration and sex on the association between siesta and hypertension
Management of nocturnal hypertension: An expert consensus document from Chinese Hypertension League
Abstract Nocturnal hypertension is highly prevalent among Chinese and Asian populations, which is mainly attributed to high salt intake and high salt sensitivity. Nocturnal hypertension increases the risk of cardiovascular and allācause mortality, independent of daytime blood pressure (BP). However, it can usually be detected by 24āh ambulatory BP monitoring, rather than routine office or home BP measurement, thus is often underdiagnosed in clinical practice. Currently, no specific guidance is available for the management of nocturnal hypertension in China or worldwide. Experts from the Chinese Hypertension League summarized the epidemiologic and pathophysiologic characteristics and clinical phenotype of nocturnal hypertension and provided consensus recommendations on optimal management of nocturnal hypertension, with the goal of maximally reducing the cardiovascular disease risks. In this consensus document, 24āh ABPM is recommended for screening and diagnosis of nocturnal hypertension, especially in the elderly, patients with diabetes, chronic kidney diseases, obstructive sleep apnea and other conditions prone to high nocturnal BP. Lifestyle modifications including salt intake restriction, exercise, weight loss, sleep improvement, and mental stress relief are recommended. Longāacting antihypertensive medications are preferred for nocturnal and 24āh BP control. Some newly developed agents, renal denervation, and other deviceābased therapy on nocturnal BP reduction are evaluated